Revolution Medicines, Inc. (RVMD) Misses Q2 EPS by 110c

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q2 EPS of ($3.06), $1.10 worse than the analyst estimate of ($1.96).

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

You May Also Be Interested In

• Paramount Weighs Tapping Musk For Equity Investment - Semafor
• Scotiabank Reiterates Sector Outperform Rating on Ero Copper Corp. (ERO:CN) (ERO)
• Rubio: Iran Meeting Was Positive But Not A Breakthrough - Bloomberg